US Antihormonal Cancer Therapies Market Driven by Rising Adoption of Targeted Hormonal Therapies
The United States Antihormonal Cancer Therapies Market represents one of the largest and most technologically advanced regional markets, supported by a strong oncology research ecosystem, extensive pharmaceutical innovation, and advanced healthcare infrastructure. The increasing prevalence of hormone-sensitive cancers, particularly breast and prostate cancer, continues to drive demand for...
0 Comments 0 Shares